BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 24176990)

  • 21. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    McGarvey L; Lee AJ; Roberts J; Gruffydd-Jones K; McKnight E; Haughney J
    Respir Med; 2015 Feb; 109(2):228-37. PubMed ID: 25613107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.
    Mapel DW; Dalal AA; Blanchette CM; Petersen H; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2011; 6():573-81. PubMed ID: 22135490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study.
    Huang WC; Wu MF; Chen HC; Hsu JY;
    PLoS One; 2018; 13(3):e0193880. PubMed ID: 29529075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 'real-life' COPD patient in Germany: The DACCORD study.
    Worth H; Buhl R; Criée CP; Kardos P; Mailänder C; Vogelmeier C
    Respir Med; 2016 Feb; 111():64-71. PubMed ID: 26775251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
    Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
    Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.
    Kornmann O; Beeh KM; Beier J; Geis UP; Ksoll M; Buhl R;
    Respiration; 2003; 70(1):67-75. PubMed ID: 12584394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).
    Montes de Oca M; López Varela MV; Laucho-Contreras ME; Casas A; Schiavi E; Rey A; Silva A;
    Arch Bronconeumol; 2017 Mar; 53(3):98-106. PubMed ID: 27956034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011.
    Marçôa R; Rodrigues DM; Dias M; Ladeira I; Vaz AP; Lima R; Guimarães M
    COPD; 2018 Feb; 15(1):21-26. PubMed ID: 29161163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seven-year cumulative incidence of COPD in an age-stratified general population sample.
    Lindberg A; Eriksson B; Larsson LG; Rönmark E; Sandström T; Lundbäck B
    Chest; 2006 Apr; 129(4):879-85. PubMed ID: 16608933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period.
    Ting SC; Crooks SW; South G
    J Epidemiol Community Health; 2011 Feb; 65(2):157-9. PubMed ID: 19996358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test.
    Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    PLoS One; 2015; 10(1):e0115787. PubMed ID: 25625286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.
    Mitsiki E; Bania E; Varounis C; Gourgoulianis KI; Alexopoulos EC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1371-82. PubMed ID: 26229456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Airflow obstruction was associated with elevation of brachial-ankle pulse wave velocity but not ankle-brachial index in aged patients with chronic obstructive pulmonary disease.
    Chen R; He W; Zhang K; Zheng H; Lin L; Nie R; Wang J; Huang H
    Atherosclerosis; 2015 Sep; 242(1):135-40. PubMed ID: 26188536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.
    Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA
    Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.